54 phd-studenship-in-computer-vision-and-machine-learning Fellowship positions at University of Michigan
Sort by
Refine Your Search
-
% - Ultrasound Data Collection and Data Analysis 30%-Conference Abstract and Manuscript Preparation Required Qualifications* PhD in Mechanical Engineering, Electrical Engineering, Computer Science, or related
-
, evidence-based care for musculoskeletal injuries and conditions. Our faculty, staff, and trainees conduct a diverse range of musculoskeletal research and scholarship. The department?s research program is
-
: Completed a doctoral degree program (MD, PhD, DrPH, EdD, or equivalent) by the starting date. Demonstrated commitment and interest in opioid-related and pain research. Research experience within a relevant
-
1850. Michigan Medicine is comprised of over 30,000 employees and our vision is to attract, inspire, and develop outstanding people in medicine, sciences, and healthcare to become one of the world’s most
-
) PhD graduate who is interested in strengthening their experimental, analytical, and publishing skills before transitioning to independence within academia or bio-pharma industry. Transferring
-
. Our faculty, staff, and trainees conduct a diverse range of musculoskeletal research and scholarship. The department?s research program is integral to its mission and vision of leading advances in
-
on December 14, 2025. All applicants are required to submit the following: A brief cover letter (max two pages) that includes a summary of the applicant's PhD research and career goals and outlines how an Erb
-
contribution to society. Required Qualifications* PhD in computer science, computational biology, or related quantitative fields. Strong oral and written communication skills Desired Qualifications* Generative
-
, such as Seurat and Scanpy. Experience with machine learning models, such as transformer and diffusion models. Strong written and oral communication skills. Modes of Work Positions that are eligible
-
Apply Now Job Summary The Nucleic Acid Therapeutics Core is a newly initiated program at the University of Michigan to design and synthesize nucleic acid therapeutic molecules for early stage